COVID Vaccines Offer Only Some Protection for People With Myeloma

By Robert PreidtHealthDay Reporter WEDNESDAY, Dec. 15, 2021 (HealthDay News) — COVID-19 vaccination provides far less protection to people with multiple myeloma than to survivors of other types of cancer, new research shows. The findings highlight the need for multiple myeloma patients “to be especially careful — to take social distancing seriously and utilize masking … Read more

Things People With Multiple Myeloma Wish You Knew

webmd logo fb

Multiple myeloma is a rare type of blood cancer that affects less than 1% of Americans. It can take a serious toll on your life. But better treatments and more awareness of the disease bring power and hope. And a diagnosis doesn’t mean you have to put your life on hold. Here are … Read more

Getting Support for Multiple Myeloma

webmd logo fb

SOURCES: Amy Pappas, myeloma patient, Cleveland, OH. Keith Guernsey, myeloma patient and coach, Gainesville, GA. Urvi Shah, myeloma specialist, Memorial Sloan Kettering Cancer Center, New York City. Jason Valent, myeloma specialist, Cleveland Clinic, Cleveland, OH. Michelle O’Hare, oncology/myeloma nurse, Memorial Sloan Kettering Cancer Center, New York City. Cancer.Net: “Multiple Myeloma: Types of Treatment.” Healthtree. Multiple … Read more

CART T Elicits Strong Response for Multiple Myeloma

Dec. 9, 2020 — For patients with heavily-pretreated multiple myeloma, the strong responses seen with the new (CAR T-cell treatment ciltacabtagene autoleucel (cilta-cel) have also been prolonged, according to investigators in the CARTITUDE-1 trial. Among 97 patients with multiple myeloma whose cancer got worse while on three or more prior types of treatment or … Read more

Multiple Myeloma Treatment: What’s New?

webmd logo fb

SOURCES: cancer,gov: “Stopping Multiple Myeloma with New Treatments” cancer.gov: “Pomalidomide for Multiple Myeloma” Cancer.gov: “Drugs Approved for Multiple Myeloma” cancer.gov: “New Use for Lenalidomide in Multiple Myeloma” Hans C. Lee, MD, University of Texas MD Anderson Cancer Center. Blood: “Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.” FDA: … Read more